What it is
A synthetic tripeptide corresponding to the C-terminal three residues (lysine-proline-valine) of alpha-melanocyte-stimulating hormone.
How it works
Proposed in preclinical studies to enter cells via PepT1 transporters and suppress NF-kappaB signaling and pro-inflammatory cytokine release in epithelial and immune cells.
Where it's used
Studied in preclinical research for anti-inflammatory effects, particularly in the gastrointestinal tract.
Regulatory status
Not FDA-approved; research compound.
Reconstitution
Lyophilized injectable forms require reconstitution with bacteriostatic water; oral capsule forms are pre-mixed.
Do the math once, not every pin. The
reconstitution calculator converts vial mg +
bacteriostatic water into exact syringe units for any target dose.
Tracking it
KPV is oral, which makes consistency the whole game — a simple daily check-off with a reminder beats memory every time.
Source
Public reference
Not medical advice. This page is an educational summary compiled from public
sources for people who log what they take. It is not a recommendation to use
KPV, a dosing guide, or a substitute for a clinician.
How we source →
Last reviewed 2026-06-11